🇺🇸 FDA
Patent

US 8097630

Pinane-substituted pyrimidinediamine derivatives useful as Axl inhibitors

granted A61PA61P13/12A61P15/00

Quick answer

US patent 8097630 (Pinane-substituted pyrimidinediamine derivatives useful as Axl inhibitors) held by Rigel Pharmaceuticals, Inc. expires Mon Jan 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Rigel Pharmaceuticals, Inc.
Grant date
Tue Jan 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61P, A61P13/12, A61P15/00, A61P17/06, A61P19/00